about
Haloperidol-induced torsade de pointesAnalysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia.Psychotropic drugs and the ECG: focus on the QTc interval.Pharmacological management of agitation in emergency settingsClinical relevance and management of drug-related QT interval prolongation.Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.Psychiatric complications in the critically ill cardiac patient.Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.Antipsychotic drugs and QTc prolongation: the potential role of CYP2D6 genetic polymorphism.Micropatterned co-culture of cardiac myocytes on fibrous scaffolds for predictive screening of drug cardiotoxicities.Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons.A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.Use of haloperidol infusions to control delirium in critically ill adults.
P2860
Q28375014-6B6ECC00-9583-4EFF-9AC3-928C0EB3490AQ30832167-0031CB89-A687-42CC-81BC-C48F9B203B1CQ34628573-769C600D-641A-4B2D-B4DC-10970F554A43Q35166653-5E665181-3E0F-488F-A064-FC9DF58F7F2BQ35186542-B88878AB-37FC-45B9-8CB5-1D83F75C9BC6Q35570977-9E7876F7-D360-4AB6-BD1F-9B00F737BEDEQ35650177-0931D912-3D92-43B9-8019-B4C4890963ADQ36048792-D86A0E8C-0832-4DE3-A36A-038DBD578A2DQ36725206-C4B148C8-B073-4EFC-9635-C69294501F79Q38851260-A468DB25-EED0-47C0-B18C-A4DF9F48144FQ44010643-2D729B84-0247-4931-8645-5850A0A895B7Q46028189-E065BD9D-C17B-435B-918F-D8BD8D08491CQ46477497-2BC08BA6-650E-4088-8269-FD89B2CABD81Q51331734-8CC8C90A-7BE6-489A-BFE7-D6B8188624AAQ51599424-775F6441-D4FB-4E53-9BF3-8FD2983324D3
P2860
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Haloperidol-induced torsades de pointes
@ast
Haloperidol-induced torsades de pointes
@en
Haloperidol-induced torsades de pointes
@nl
type
label
Haloperidol-induced torsades de pointes
@ast
Haloperidol-induced torsades de pointes
@en
Haloperidol-induced torsades de pointes
@nl
prefLabel
Haloperidol-induced torsades de pointes
@ast
Haloperidol-induced torsades de pointes
@en
Haloperidol-induced torsades de pointes
@nl
P2093
P356
P1433
P1476
Haloperidol-induced torsades de pointes
@en
P2093
P356
10.1378/CHEST.98.2.482
P407
P577
1990-08-01T00:00:00Z